December 21, 2023
2 mins read

WHO Declares JN.1 as Standalone Covid Variant

Though JN.1 is now restricted to its circulation in the US, it is responsible for an estimated 1 in 5 new coronavirus infections, according to data from the Centers for Disease Control and Prevention…reports Asian Lite News

The World Health Organization (WHO) has declared the new Covid-19 variant — JN.1 — as a “standalone variant of interest”.

WHO’s decision was prompted by the variant’s ability to spread fast among the community. It said the decision was due to the strain’s ‘rapidly increasing spread’.

The WHO on Tuesday announced that it is classifying a new Covid-19 strain – JN.1 – as a standalone variant of interest “due to its rapidly increasing spread”, media reports said adding that the new variants’ characteristics and a growth advantage over other strains in circulation prompted the early warning, reports said.

Though WHO assessed the global public health risk of JN.1 as low, it warned that countries approaching winter should be aware that Covid-19 and other pathogens may exacerbate respiratory disease seasons.

“Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries,” it said.

Though JN.1 is now restricted to its circulation in the US, it is responsible for an estimated 1 in 5 new coronavirus infections, according to data from the Centers for Disease Control and Prevention.

The agency expects that JN.1’s prevalence in the US will continue to increase in the winter months.

WHO considers BA.2.86 sub lineages to be variants of interest, but now JN.1 is listed as a variant of interest separate from its parent lineage, also known as pirola.

WHO defines a variant of interest as a strain with genetic mutations, according to US News & World Report.

Covid-19 tests and treatments are expected to work on JN.1. So far, it doesn’t appear to cause more severe disease but it does seem to have advantages over the other strains.

“While there is a rapid increase in JN.1 infections, and likely increase in cases, available limited evidence does not suggest that the associated disease severity is higher as compared to other circulating variants,” WHO said in its risk assessment of the strain.

Coronavirus vaccines are also expected to work on JN.1. “Current vaccines, including those based on ancestral strain as well as the updated monovalent XBB vaccines continue to provide protection against severe disease and death, including against JN.1,” WHO’s Maria Van Kerkhove said on social media.

ALSO READ-India Topped SE Asia in Malaria Cases and Deaths: WHO

Previous Story

Controversial Colorado Ruling Spurs GOP Action

Next Story

India Emphasizes Counter terrorism Efforts in Afghanistan

Latest from -Top News

Hamas Reiterates Peace Effort After U.S. Jab

Hamas Reaffirms Commitment to Ceasefire Talks After U.S. Criticism…reports Asian Lite News Hamas on Friday reiterated its commitment to the ongoing ceasefire negotiations, responding to remarks by U.S. Special Envoy to the

No smoking gun in Epstein files: Trump briefed

Attorney General Pam Bondi briefed Trump and Deputy Attorney General Todd Blanche at the White House in May….reports Asian Lite News US President Donald Trump was informed earlier this year that his

Israel, US recall teams from Gaza truce talks

Steve Witkoff said mediators had made a great effort but “Hamas does not appear to be coordinated or acting in good faith”…reports Asian Lite News Israel and the United States recalled their

Trump presses Fed chief to cut rates

Fed chair pushes back on Trump criticism of renovation costs as president presses central bank to cut interest rates…reports Asian Lite News Donald Trump sparred with the Federal Reserve chair, Jerome Powell,

Dubai turns malls Into fitness zones

Dubai’s Mallathon reimagines shopping centres as fitness zones, encouraging residents of all ages to walk, run, and connect—fostering healthier habits in air-conditioned comfort….reports Asian Lite News In a bold move to blend
Go toTop

Don't Miss

Britain extends Covid-19 booster jab to people over 40

The JCVI also advised that all 16- to 17-year-olds who

Two million Britons may have suffered long Covid

The findings were based on data from 508,707 adults who